Plasmid DNA Endotoxin Reduction via MDS Bacterial Hosts
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing plasmid DNA as therapeutic agents fail to completely eliminate endotoxins, particularly from bacterial hosts like E. coli, which are essential for viability and cannot be wholly deleted without being lethal, limiting the reduction of endotoxin levels in DNA preparations.
Innovation Solution
Utilizing multiple deletion strain (MDS) bacteria lacking genes involved in lipopolysaccharide and enteric common antigen production, such as msbB, to grow plasmid DNA, which reduces endotoxin levels through genetic means, thereby minimizing contaminants and improving purification efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If standard bacterial strains (e.g., E. coli) are used to produce plasmid DNA, then robust growth and high DNA yield are achieved, but endotoxin levels remain high and cannot be completely eliminated
Solution Approach 1:
The patent modifies the genetic parameters of the bacterial host by deleting specific genes (msbB, rfa, waa, bgaA) involved in lipopolysaccharide biosynthesis. This genetic parameter change fundamentally alters the bacterial cell's endotoxin production capability, reducing endotoxin levels by 1000-10000 fold while preserving the ability to support plasmid DNA replication and bacterial growth.
Solution Approach 2:
The patent extracts and removes specific harmful genetic elements (endotoxin biosynthesis genes) from the bacterial genome while retaining the essential functions needed for plasmid production. By selectively deleting genes responsible for LPS synthesis, the harmful endotoxin component is extracted from the system without compromising the overall productivity of plasmid DNA generation.
2Object-generated harmful factors
If multiple gene deletions are performed to reduce endotoxin, then endotoxin levels decrease significantly, but bacterial viability and growth capacity may be compromised
Solution Approach 1:
The patent applies local quality modification by specifically targeting and deleting only the genes responsible for endotoxin biosynthesis (msbB, rfa, waa, bgaA) while leaving the rest of the bacterial genome intact. This localized genetic modification ensures that essential functions for bacterial viability and plasmid production remain unchanged, while only the harmful endotoxin production is eliminated.
Solution Approach 2:
The patent converts the harmful effect of endotoxin production into a benefit by creating a bacterial strain that is inherently low-endotoxin or endotoxin-free. The deleted genes that previously caused harm (endotoxin-mediated immune responses and purification complications) are transformed into an advantage, producing plasmid DNA with dramatically reduced endotoxin contamination without requiring additional purification steps.
3Ease of manufacture
If conventional purification methods are used, then plasmid DNA is recovered, but endotoxin contaminants remain in the final preparation
Solution Approach 1:
The patent performs preliminary action by genetically modifying the bacterial host before plasmid DNA production to eliminate endotoxin biosynthesis capability. This preemptive genetic modification ensures that endotoxins are not produced during bacterial growth and plasmid replication, so the starting material for purification is already low-endotoxin, eliminating the need for specialized endotoxin removal steps.
Solution Approach 2:
The genetically modified bacterial strain serves itself by inherently producing low-endotoxin plasmid DNA through its altered metabolism. The bacteria's own genetic makeup (lacking endotoxin biosynthesis genes) automatically ensures that the plasmid DNA it produces is free from endotoxin contamination, without requiring external intervention or additional purification mechanisms.
Data Source
AI summary
The various embodiments of the present invention relate generally to plasmid DNA preparations and to methods for producing and using such preparations.